By AMERICAN HEART ASSOCIATION NEWS A pair of cholesterol-lowering drugs called PCSK9 inhibitors were controversial as soon as they hit the market in 2015. They cost an average $14,300 a year, and prescriptions require prior authorization by health insurance companies — which a new study shows isn’t a guarantee. Only […]
The post Half of patients denied insurance coverage of new cholesterol drugs appeared first on News on Heart.org.
from News on Heart.org http://ift.tt/2z5lzZn
No comments:
Post a Comment